Innovative healthtech firm Luna and fertility benefits provider Kindbody have confirmed a strategic partnership aimed at bringing personalised data to the reproductive health sector. The collaboration will integrate Luna’s advanced smart wearables into Kindbody’s care delivery platform. This move allows for a clearer understanding of the daily physiological shifts that impact fertility, most of which occur outside of a traditional clinical setting.
The partnership focuses on using continuous biomarker sensing to track variables such as recovery, sleep patterns, stress and hormonal rhythms. By bringing these signals into view, Kindbody’s care teams can gain a more holistic and contextualised understanding of a patient’s health. This data-driven approach is intended to make the path to parenthood more informed and supportive for individuals and couples.
“The conception journey is one of the most meaningful and complex chapters in a person’s life, and it deserves both deep empathy and deep intelligence,” said Amit Khatri, Founder of Luna. “By uniting Luna’s continuous biomarker sensing with Kindbody’s world-class clinical expertise, we are giving patients a clearer window into their bodies and giving physicians a new dimension of insight that can elevate the entire care experience. This partnership represents the future of reproductive health: connected, personalized, and profoundly human.”
As part of the agreement, Luna’s technology will be embedded within the Kindbody ecosystem. This will provide fertility patients with a more connected experience as they navigate their care. Kindbody is a leading provider of family-building benefits and operates a wide network of fertility clinics.
“This partnership with Luna represents a significant step forward in making fertility care smarter and more personalized,” said David Stern, CEO of Kindbody. “By leveraging data-driven insights, we can better support patients and providers alike, ensuring every decision is informed, effective, and centered on the needs of those on their fertility journey.”
The integration of wearable technology is seen as a major shift in how reproductive health is managed. By providing physicians with a new dimension of insight, the partnership aims to elevate the standard of care for fertility patients. Both companies believe that the combination of clinical expertise and real-time data marks the beginning of a more intelligent era for women’s healthcare.
